We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

Xponance Inc. grew its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 4.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

Pfizer Inc. is currently one of the top profitable value stocks to consider. Its forward P/E ratio of 8.66 makes it a highly attractive investment option. Pfizer's recent acquisition of Seagen has ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from the tariff wars, Maggie Fick of ...

We’re in a somewhat unusual economic predicament right now. On one hand, inflation remains high (at least compared to the Federal Reserve’s target of 2%). On the other, inflation has been coming down ...

The First Trust Morningstar Dividend Leaders Index Fund has outperformed the S&P 500 year-to-date and LTM. See why FDL ETF is ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.

The finance sector is strongly represented in this year’s attendees. HSBC Group Chief Executive Georges Elhedery is on the ...